— Know what they know.
Not Investment Advice
Also trades as: 092730.KS (KSC) · $vol 0M

092730.KQ KOE

NeoPharm Co. Ltd.
1W: -2.3% 1M: -4.9% 3M: +24.9% YTD: +15.6% 1Y: +22.7% 3Y: +11.4% 5Y: -22.8%
₩23,100.00 ($17.16)
-200.00 (-0.86%)
 
Weekly Expected Move ±5.0%
₩20781 ₩21940 ₩23100 ₩24260 ₩25419
KOE · Consumer Defensive · Household & Personal Products · Tech Score Buy · Power 49 · ₩361.3B mcap · 9M float · 0.711% daily turnover

Income Trends

Revenue
$132.2B +11.1% ▲
5Y CAGR: +10.1%
Gross Profit
$84.7B +14.4% ▲
5Y CAGR: +8.0%
Operating Income
$28.8B +16.7% ▲
5Y CAGR: +5.6%
Net Income
$27.9B +21.0% ▲
5Y CAGR: +9.0%
EPS (Diluted)
$1778.81 +20.7% ▲
5Y CAGR: +9.2%
EBITDA
$31.9B -4.4% ▼
5Y CAGR: +5.5%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$87.9B$85.0B$97.1B$119.0B$132.2B
YoY Growth+7.7%-3.3%+14.2%+22.6%+11.1%
Cost of Revenue$26.6B$27.8B$33.0B$45.0B$47.5B
Gross Profit$61.3B$57.3B$64.2B$74.0B$84.7B
Gross Margin69.7%67.4%66.1%62.2%64.1%
R&D Expenses$2.9B$2.9B$2.6B$3.4B$3.3B
SG&A Expenses$36.0B$33.0B$36.3B$33.5B$52.6B
Operating Expenses$38.9B$35.8B$38.9B$49.4B$55.9B
Operating Income$22.4B$21.4B$25.3B$24.7B$28.8B
Operating Margin25.5%25.2%26.1%20.7%21.8%
Interest Expense$38M$9M$21M$41M$39M
Income Before Tax$23.8B$23.3B$29.4B$30.2B$32.3B
Tax Expense$6.1B$6.3B$6.2B$7.1B$4.4B
Net Income$17.7B$17.0B$23.2B$23.1B$27.9B
Net Margin20.1%20.0%23.9%19.4%21.1%
EPS (Diluted)$1132.50$1088.50$1484.00$1473.56$1778.81
EBITDA$25.3B$24.9B$31.0B$33.3B$31.9B
Shares Outstanding8M8M8M16M16M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms